Mirae Asset Global ETFs Holdings’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
VCM
OFM
LCM
DFO
Mirae Asset Global ETFs Holdings's NUVB Position: Q1 2026 in Review
Mirae Asset Global ETFs Holdings increased its Nuvation Bio (NUVB) stake by 0.87% in Q1 2026, buying an estimated $5.46K and bringing the position to 113,020 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #1903.
Mirae Asset Global ETFs Holdings first reported a position in NUVB in Q2 2024 and has held it in 8 quarters since. The position peaked at $1M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.
- Mirae Asset Global ETFs Holdings held 113,020 shares of Nuvation Bio worth $485K as of Q1 2026.
- Mirae Asset Global ETFs Holdings bought 980 Nuvation Bio shares in Q1 2026, an estimated $5.46K.
- Nuvation Bio made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1903 holding.
- Mirae Asset Global ETFs Holdings first reported a position in Nuvation Bio in Q2 2024 and has held it in 8 quarters since.
- Mirae Asset Global ETFs Holdings's Nuvation Bio position peaked at $1M in Q4 2025.
- 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.